Pharmacological evaluation of leukotriene biosynthesis and inflammation in an adoptive model of peritoneal anaphylaxis in the mouse
- 1 October 1993
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 30 (2) , 83-90
- https://doi.org/10.1002/ddr.430300207
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibition of leukotriene biosynthesis in the rat peritoneal cavityEuropean Journal of Pharmacology, 1991
- Pharmacology of the pyrroloimidazole, SK&F 105809—II: Antiinflammatory activity and inhibition of mediator production in vivoBiochemical Pharmacology, 1991
- Pharmacology of the pyrroloimidazole, SK&F 105809—I: Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acidBiochemical Pharmacology, 1991
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Selective 5-lipoxygenase inhibition in ulcerative colitisThe Lancet, 1990
- Release of eicosanoids in rat peritonial cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacinInternational Journal of Immunopharmacology, 1989
- The role of eicosanoids in inflammationProgress in Lipid Research, 1986
- Leukotrienes in inflammationInflammation Research, 1986
- Leukotriene B4General Pharmacology: The Vascular System, 1981
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980